NAGS and lung adenocarcinoma: This suggests markedly lower NAGS and CPS1 expression in glioblastoma multiforme, glioma, lung adenocarcinoma, stomach adenocarcinoma, and stomach and esophageal carcinoma than in the liver and small intestine.